DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
mitment to buildinga healthy caring community DaVita develops participates in and donatesto numerous programs dedicated to transforming communities and creatingpositive sustainable change for children families and our environment.For more information about DaVita its kidney education and its communityprograms please visit http://www.davita.
Date:6/23/2008
mitment to building
a healthy, caring community, DaVita develops, participates in and donates
to numerous programs dedicated to transforming communities and creating
positive, sustainable change for children, families and our environment.
For more information about DaVita, its kidney education and its community
programs, please visit
http://www.davita.com.
'/>"/>SOURCE DaVita Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine technology :1.
DaVita Clinical Research Completes Record Number of Renal Trials in 20072.
Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients3.
Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO084.
Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome5.
Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis6.
Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis7.
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder8.
After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 20089.
CherryPharm First All-Natural Food to Improve Sleep10.
Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes11.
Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight